育薬創薬研究センターが関与した臨床研究、附属薬局が関与した臨床教育に関する発表論文

2022年

Yoshihiro NOGUCHI，Shunsuke YOSHIZAWA，Tomoya TACHI，Hitomi TERAMACHI，Effect of Dipeptidyl peptidase-4 inhibitors vs. metformin on major cardiovascular events using spontaneous reporting system and real-world database study, J. Clin. Med. 1, 4988, doi: 10.3390/jcm11174988, 2022.

Yu KONDO, Tomoya TACHI, Takayoshi SAKAKIBARA, Jun KATO, Aki KATO, Takahito MIZUNO, Yoshio MIYAKE, Hitomi TERAMACHI, Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan. Support Care Cancer. 30, 6775-6783, 2022.

野口義紘, 舘知也, 伊野陽子, 山下修司, 玉木啓文, 長内理大, 井口和弘, 寺町ひとみ，岐阜薬科大学附属薬局における改訂モデル・コアカリキュラムに対応した実習状況，日本地域薬局薬学会誌 10，14-26，2022．

Yu KONDO, Tomoya TACHI T, Takayoshi SAKAKIBARA, Jun KATO, Takahito MIZUNO, Yoshio MIYAKE, Hitomi TERAMACHI, Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy. J. Pharm. Health. Care. Sci., 8,15, doi: 10.1186/s40780-022-00246-x, 2022.

桜田宏明，内藤和行，寺町ひとみ，愛知県公立病院における抗がん剤購入費比率の調査，癌と化学療法，49，53-57，2022．

Hasegawa S, Ikesue H, Satake R, Inoue M, Yoshida Y, Tanaka M, Matsumoto K, Wakabayashi W, Oura K, Muroi N, Hashida T, Iguchi K, Nakamura M. Osteonecrosis of the Jaw Caused by Denosumab in Treatment-naïve and Pre-treatment with Zoledronic Acid Groups in Patients: A Time-to-Onset Study of Using the Japanese Adverse Drug Event Report (JADER) database. Drugs - Real World Outcomes, 2022. 9.

Yoshida Y, Sasaoka S, Tanaka M, Matsumoto K, Inoue M, Satake R, Shimada K, Mukai R, Suzuki T, Iwata M, Goto F, Mori T, Mori K, Yoshimura T, Nakamura M. Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database. Therapeutic Advances in Drug Safety, 2022. 13,1-12.

Fujii H, Sadaka S, Ajisawa K, Okumura N, Makiyama A, Iihara H, Yasufuku I, Ohata K, Kobayashi R, Tanaka Y, Hayashi H, Suzuki A, Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer. Anticancer Res., 42: 4581-4588，2022．

Fujii H, Ueda Y, Hirose C, Ohata K, Sekiya K, Kitahora M, Sadaka S, Yamamoto S, Watanabe D, Kato-Hayashi H, Iihara H, Kobayashi R, Kaburaki M, Matsuhashi N, Takahashi T, Makiyama A, Yoshida K, Hayashi H, Suzuki A, Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy. J Pharm Health Care Sci., Mar 2;8(1):8. doi: 10.1186/s40780-022-00239-w，2022．

Uno A, Yamamoto S, Iihara H, Fujii H, Makita C, Hayasaki Y, Ueda Y, Ito M, Takenaka M, Kumano T, Mori M, Yasue M, Kato-Hayashi H, Kobayashi R, Morishige K, Matsuo M, Hayashi H, Suzuki A, Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving Radiotherapy. Anticancer Res., 42: 3117-3123 (2022)

中島誠, 高橋武士, 中木原由佳, 林秀樹, 検体採取日の違いが入院患者のアンチバイオグラムに及ぼす影響に関する検討. 医薬品情報学, 23: 155-165，2022．

市江敏和、森﨑真理子、森理乃、荒川泰代、大谷寧次郎、三浦毅、林秀樹, 新型コロナウイルス感染症流行下における医薬情報担当者からの情報提供方法の変更が業務に及ぼす影響. 医薬品情報学, 24: 111-120，2022．

Todoroki　K, Isobe R, Yamada T, Saito T, Shimizu Y, Tsukakoshi K, Sugiyama E, Mizuno H, Hayashi H, Ikebukuro K, Development of a Lateral Flow Assay for Bevacizumab Using an Anti-Idiotype DNA Aptamer as a Capture Molecule. Chromatography, 43: 73-77，2022．

廣瀬達也, 種田靖久, 藤田崚介, 杉山智紀, 宮下澪, 蜜田哲也, 浅野裕紀, 松村知洋, 林秀樹, 吉村知哲, 的確な災害時安否連絡を目的とし作成された携帯型災害対応マニュアルのCustomer satisfaction分析評価. 日本臨床救急医学会雑誌, 25: 28-34，2022．

2021年

Yoshihiro NOGUCHI, Azusa MURAYAMA, Hiroki ESAKI, Mayuko SUGIOKA, Aisa KOYAMA, Tomoya TACHI, Hitomi TERAMACHI, Angioedema caused by drugs that prevent the degradation of vasoactive peptides: a pharmacovigilance database study, J. Clin. Med., 10, 5507. doi: 10.3390/jcm10235507, 2021.

Hayato KATSUNO, Tomoya TACHI, Takuya MATSUYAMA, Mayuko SUGIOKA, Satoshi AOYAMA, Tomohiro OSAWA, Yoshihiro NOGUCHI, Masahiro YASUDA, Chitoshi GOTO, Takashi MIZUI, Hitomi TERAMACHI, Evaluation of the direct costs of managing adverse drug events in all ages and of avoidable adverse drug events in older adults in Japan, Front. Pharmacol., 12, 761607. doi: 10.3389/fphar.2021.761607, 2021.

Keiko SUZUKI, Hironori FUJII, Tomoyo YAMAUCHI, Hiroko KATO-HAYASHI, Masashi ISHIHARA, Hirotoshi IIHARA, Chiemi HIROSE, Shohei NISHIDA, Miyui FUNATO, Ryo KOBAYASHI, Koji YASUDA, Yoko INO, Hirofumi TAMAKI, Shuji YAMASHITA, Kazuhiro IGUCHI, Yoshihiro NOGUCHI, Hitomi TERAMACHI, Jun TAKADA, Masaya KUBOTA, Takashi IBUKA, Hiroshi ARAKI, Masahito SHIMIZU, Akio SZUKI, J. Pharm. Pract. Res., 51, 374-380, 2021.

林剛，舘知也，野口義紘，杉岡まゆ子，青山智，田中和秀，安田昌宏，後藤千寿，山田浩司，水井貴詞，寺町ひとみ，ナトリウム・グルコース共輸送体-2（SGLT2）阻害薬に関するリスク管理計画におけるリスク最小化活動の評価－国内自発報告データベースおよび実臨床データを用いた解析－，医療薬学，47，464-476，2021．

Yoshihiro NOGUCHI, Shunsuke YOSHIZAWA, Keisuke AOYAMA, Satoaki KUBO, Tomoya TACHI, Hitomi TERAMACHI, Verification of the "Upward Variation in the Reporting Odds Ratio Scores" to Detect the Signals of Drug-Drug Interactions, Pharmaceutics, 13, 1531. doi: 10.3390/pharmaceutics13101531, 2021.

Masahiro YASUDA, Tomoya TACHI, Tomohiro OSAWA, Hisataka WATANABE, Seiji INOUE, Teppei MAKINO, Katsuhiro NAGAYA, Miho MORITA, Kazuhide TANAKA, Satoshi AOYAMA, Tomohiro OSAWA, Senji KASAHARA, Hitomi TERAMACHI, Takashi MIZUI, Risk factors for thrombocytopenia and analysis of time to platelet transfusion after azacitidine treatment, Pharmazie, 76, 444-449, 2021.

青山京介，舘知也，髙岡みらい，久保賢晃，林剛，野口義紘，寺町ひとみ，大学での簡易懸濁法実習の実務実習における活用状況調査，日本服薬支援研究会誌，9．5-10，2021．

Tomoya TACHI, Manami OTSUBO, Manabu TOYOSHIMA, Hayato KATSUNO, Anri UENO, Yoshihiro NOGUCHI, Satoshi AOYAMA, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi TERAMACHI, What activities of daily living at discharge affect the discharge destination of patients in an acute-care hospital in Japan: A retrospective factor analysis, Int. J. Health Plann. Manage., 36, 1326-1337, 2021.

久保賢晃，舘知也，髙岡みらい，青山京介，林剛，野口義紘，寺町ひとみ，薬剤師として求められる基本的な資質，社会的スキルおよび薬剤師コミュニケーションスキルに対する実務実習の効果～学生への自己評価アンケート調査～，医療薬学，47，279-292，2021．

Takuya MATSUYAMA, Tomoya TACHI, Hayato KATSUNO, Mayuko SUGIOKA, Satoshi AOYAMA, Tomohiro OSAWA, Aisa KOYAMA, Azusa MURAYAMA, Yoshihiro NOGUCHI, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi TERAMACHI, Effects of polypharmacy on the prevalence of adverse drug events resulting in outpatient visits and hospitalization, Pharmazie, 76, 279-286, 2021.

Tomoya TACHI, Manami OTSUBO, Manabu TOYOSHIMA, Azusa MURAYAMA, Hayato KATSUNO, Anri UENO, Yoshihiro NOGUCHI, Satoshi AOYAMA, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi TERAMACHI, The association between polypharmacy and the efficiency of the functional independence measure in an acute-stage hospital: a retrospective cohort study, Aging Clin. Exp. Res., 33, 983-990 2021.

Yoshihiro NOGUCHI, Keisuke AOYAMA, Satoaki KUBO, Tomoya TACHI, Hitomi TERAMACHI, Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio, Pharmaceuticals, 14, 4. doi: 10.3390/ph14010004, 2021.

Manabu TOYOSHIMA, Yoshihiro NOGUCHI, Manami OTSUBO, Tomoya TACHI, Hitomi TERAMACHI, Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system, Int. J. Med. Sci., 18, 1130-1136. doi:10.7150/ijms.51658, 2021.

井口和弘，山下修司，玉木啓文，野口義紘，長内理大，伊野陽子，寺町ひとみ．オンラインで実施した薬剤師対象のリカレント講座における受講者満足度に関する調査．日本地域薬局薬学会誌 9, 21-26, 2021.

Umetsu R, Tanaka M, Nakayama Y, Kato Y, Ueda N, Nishibata Y, Hasegawa S, Matsumoto K, Takeyama N, Iguchi K, Tanaka H, Hinoi E, Inagaki N, Inden M, Muto Y, Nakamura M. Neuropsychiatric adverse events of montelukast: an analysis of real-world datasets and drug−gene interaction network. Frontiers in Pharmacology, 2021. 12, 764279.

Nakao S, Hasegawa S, Umetsu R, Shimada K, Mukai R, Tanaka M, Matsumoto K, Yoshida Y, Inoue M, Satake R, Nishibata Y, Liao J, Nakamura M. Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese Adverse Drug Event Report database. BMC Pharmacology and Toxicology, 2021. 22, 47.

Tanaka M, Matsumoto K, Satake R, Yoshida Y, Inoue M, Hasegawa S, Suzuki T, Iwata M, Iguchi K, Nakamura M. Gentamicin-induced hearing loss: a retrospective study using the Food and Drug Administration Adverse Event Reporting System and a toxicological study using drug−gene network analysis. HELIYON, 2021.7, e07429.

Satake R, Matsumoto K, Tanaka M, Mukai R, Shimada K, Yoshida Y, Inoue M, Hasegawa S, Iguchi K, Ikesue H, Shimizu S, Nishida S, Suzuki A, Hashida T, Nakamura M. Analysis of drug-induced gastrointestinal obstruction and perforation using the Japanese Adverse Drug Event Report database. Frontiers in Pharmacology, 2021.12, 692292.

Inoue M, Matsumoto K, Tanaka M, Yoshida Y, Satake R, Goto F, Shimada K, Mukai R, Hasegawa S, Suzuki T, Ikesue H, Liao J, Hashida T, Nakamura M. Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database. Scientific Reports, 2021. 11, 11324.

Shimizu S, Hayashi Y, Nishida S, Fujii H, Nakamura M, Yoshikura N, Nagano A, Kitagawa J, Kanemura N, Mizutani K, Kobayashi R, Ishihara T, Hayashi H, Shimohata T, Sugiyama T, Suzuki A, Albumin-bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy, Journal of Clinical Pharmacy and Therapeutics, 46: 794-799, 2021.

Fujii H, Koda M, Sadaka S, Ohata K, Kato-Hayashi H, Iihara H, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Hayashi H, Sugiyama T, Shimizu M, Suzuki A, Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study. Journal of Pharmaceutical Health Care and Sciences, 2021 Aug 2;7(1):27. doi: 10.1186/s40780-021-00210-1.

Noro R, Igawa S, Bessho A, Hirose T, Shimokawa T, Nakashima M, Minato K, Seki N, Tokito T, Harada T, Sasada S, Miyamoto S, Tanaka Y, Furuya N, Kaburagi T, Hayashi H, Iihara H, Okamoto H, Kubota K, A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632, Lung Cancer, 161: 49-54, 2021.

山田紘嗣, 山田悠人, 小林亮, 林秀樹, 鈴木昭夫, 上野隆, 光触媒を利用した抗がん薬分解フィルムの開発, 癌と化学療法, 48: 933 - 937, 2021.

Fujibayashi A., Niwa T., Yonetamari J., Ito-Takeichi S., Suzuki K., Ohta H., Niwa A., Tsuchiya M., Ito Y., Hatakeyama D., Hayashi H., Sugiyama H., Baba H., Suzuki A., Murakami N.: Clinical impact of monitoring frequency per day as a prospective audit and feedback strategy for patients receiving antimicrobial agents by injection. Int. J. Clin. Pract., 75: e14785. doi: 10.1111/ijcp.14785, 2021.

Kitagawa J., Kobayashi R., Nagata Y., Kasahara S., Ono T., Sawada M., Ohata K., Kato-Hayash H., Hayashi H., Shimizu M., Itoh Y., Tsurumi H., Suzuki A.: Polaprezinc for Prevention of Oral Mucositis in Patients Receiving Chemotherapy Followed by Hematopoietic Stem Cell Transplantation: A Multi-institutional Randomized Controlled Trial. Int. J. Cancer, 148:1462-1469, 2021.

2020年

Mayuko SUGIOKA, Tomoya TACHI, Takashi MIZUI, Aisa KOYAMA, Azusa MURAYAMA, Hayato KATSUNO, Takuya MATSUYAMA, Satoshi AOYAMA, Tomohiro OSAWA, Yoshihiro NOGUCHI, Masahiro YASUDA, Chitoshi GOTO, Hitomi TERAMACHI, Effects of the number of drugs used on the prevalence of adverse drug reactions in children, Sci. Rep., 10, 21341. doi: 10.1038/s41598-020-78358-3, 2020.

Yoshihiro NOGUCHI, Mirai TAKAOKA, Tsuyoshi HAYASHI, Tomoya TACHI, Hitomi TERAMACHI, Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database, Epilepsia, 61, 1979-1989, 2020.

林剛，舘知也，髙岡みらい，野口義紘，寺町ひとみ，処方提案や疑義照会におけるチームワーク悪化・ストレス発生に影響する信念対立因子の解明─多変量解析とベイジアンネットワーク解析─，YAKUGAKU ZASSHI，140，1151-1164，2020．

Yoshihiro NOGUCHI, Tomoya TACHI, Hitomi TERAMACHI, Subset Analysis for Screening Drug-Drug Interaction Signal Using Pharmacovigilance Database, Pharmaceutics, 12, E762. doi: 10.3390/pharmaceutics12080762, 2020.

Yoshihiro NOGUCHI, Tomoya TACHI, Hitomi TERAMACHI, Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems, Pharm. Res., 37, 86. doi: 10.1007/s11095-020-02801-3, 2020.

Yoshihiro NOGUCHI, Hiroki ESAKI, Azusa MURAYAMA, Mayuko SUGIOKA, Aisa KOYAMA, Tomoya TACHI, Hitomi TERAMACHI, Association between Dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan, Eur. J. Clin. Pharmacol., 76, 299-304, 2020.

Tomoya TACHI, Yumi TODA, Takayuki SEKO, Yoshihiro NOGUCHI, Hitomi TERAMACHI, Impact of infection control measures on the related costs and the amount of broad-spectrum antimicrobial agents used in a hospital: a time-series analysis, Int. J. Health Plann. Manage., 35, e133-e141. doi: 10.1002/hpm.2944, 2020.

Tomoya TACHI, Yoshihiro NOGUCHI, Hitomi TERAMACHI, Developing and Verifying the Efficacy of "Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists": A Randomized Controlled Trial, Biol. Pharm. Bull.,43, 77-86, 2020.

小長谷奈美，長内理大，小俣江利果，島内あかり，伊野陽子，玉木啓文，山下修司，野口義紘，井口和弘, 寺町ひとみ． 岐阜薬科大学附属薬局における電話相談内容の解析調査．医療薬学46, 515-521, 2020.

森美穂，島内あかり，矢島聖子，西尾裕斗，玉木啓文，堺千紘，長内理大，伊野陽子，寺町ひとみ，中村光浩，井口和弘．機能性表示食品の包装の情報記載状況に関する調査．薬学雑誌140, 443-448, 2020.

大場次郎, 佐藤栄一, 山岸庸太, 渡邉暁洋, 林　秀樹, 寺田千香子, バヌアツ共和国におけるサイクロンパム被害に対する日本国際緊急援助隊医療チームのビラ中央病院への医療支援. 日本災害医学会雑誌, 25: 42-47, 2020.

Nishida S., Hayashi Y., Hirai K., Takekoshi A., Yamada Y., Kobayashi R., Shimizu S., Niwa T., Hayashi H., Shimohata T., Sugiyama T., Suzuki A.: Effect of therapeutic plasma exchange on phenytoin plasma concentration in patients receiving intravenous fosphenytoin therapy. Pharmazie, 75: 488-490, 2020.

Todoroki K., Nakano T., Hayashi H., Mizuno H., Min J.Z., Toyo'oka T., Fluorescence Bioanalysis of Bevacizumab Using Pre-Column and Post-Column Derivatization - Liquid Chromatography After Immunoaffinity Magnetic Purification. Chromatography, 41: 115-122, 2020.

中島誠、馬見　塚勝郎、甲斐絢子、林秀樹, 緩和ケア病棟におけるポリファーマシーの経時的調査. 医療薬学, 46: 551-560, 2020.

中村宏洋，甲斐絢子，小原道子，林秀樹，杉山正, カルシウム拮抗薬内服患者の浮腫発現状況と浮腫発現関連因子の検討―保険薬局における薬剤服用歴の分析―. 日本地域薬局薬学会誌, 8: 127-133, 2020.

上田祐稀乃、鈴木学、清木静乃、海野茜、甲斐絢子、小原道子、林秀樹、棚瀬友啓、日比野靖、杉山正、保険薬局における健康相談内容の特徴の分析. 日本地域薬局薬学会誌, 8: 78-88, 2020.

Nakamura K, Nagata S, Kai J, Obara M, Hayashi H, Sugiyama T, Prodromal Symptoms of Cholinergic Crisis Following Appropriate Administration of Rivastigmine Patch, Ther. Res., 41: 355-357, 2020.

中村宏洋, 永田俊一, 甲斐絢子, 小原道子, 林秀樹, 杉山正, 第一世代抗ヒスタミン薬を含有するOTC医薬品により認知機能障害が悪化した混合型認知症の1例. セラピューティック リサーチ, 41: 351-354, 2020.

海野茜, 鈴木学, 上田祐稀乃, 小林篤史, 甲斐絢子, 生木庸寛, 小原道子, 味澤香苗, 林由依, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正, 重複投与・相互作用等防止加算業務の経済効果とその要因―岐阜県におけるPharmaceutical Intervention Record（薬学的介入報告）の分析―, 日本地域薬局薬学会誌, 8: 50-61, 2020.

上田祐稀乃, 鈴木学, 海野茜, 甲斐絢子, 小原道子, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正, 医療機関を定期受診している来局者と定期受診していない来局者の保険薬局における健康相談内容の比較. 日本地域薬局薬学会誌, 8: 42-49, 2020.

小林篤史, 甲斐絢子, 林秀樹, 森山文則, 渡辺康介, 杉山正. 薬学生に対する在宅医療研修プログラムの開発とその評価. 在宅薬学, 7: 49-56, 2020.

海野茜, 鈴木学, 上田祐稀乃, 小林篤史, 甲斐絢子, 生木庸寛, 小原道子, 味澤香苗, 林由依, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正. 薬剤中止を結果とした疑義照会の特徴と経済効果. セラピューティック リサーチ, 41: 341-349, 2020.

小林篤史, 國府田真綾, 甲斐絢子, 小原道子, 林秀樹, 丹羽智子, 棚瀬友啓, 日比野靖, 杉山正. 薬学生がスタッフとして参加した薬剤師在宅医療技術研修会の評価. セラピューティック リサーチ, 41: 117-124, 2020.

上田祐稀乃, 鈴木学, 海野茜, 甲斐絢子, 小林篤史, 小原道子, 生木庸寛, 味澤香苗, 林由依, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正. 残薬に伴う日数・投与総数の調整を原因とした処方監査の分析と経済効果. 日本地域薬局薬学会誌, 8: 13-23, 2020.

海野茜, 鈴木学, 上田祐稀乃, 小林篤史, 甲斐絢子, 生木庸寛, 小原道子, 味澤香苗, 林由依, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正. 在宅医療患者に対する処方監査の特徴―岐阜県におけるPharmaceutical Intervention Record（薬学的介入報告）の分析―. 在宅薬学, 7: 24-32, 2020.

Obara M., Hayashi H. (co-first & corresponding author), Namaki N., Furushima D., Matsukawa T., Kato R., Yamada H., Suzuki D., Sugiyama T. Effects of food containing aroma compounds on oral hygiene: a preliminary pilot clinical study in elderly people requiring care. Ther. Res., 41: 125-131, 2020.

Takizawa Y., Nishizawa S., Kazama M., Shibata H., Nakamura M., Ishizaka K., Hayashi H., Kai J., Sugiyama T. A Case of Inoperable Gastric Cancer with Right Ventricular Metastasis Treated with Nivolumab. Jpn. Pharmacol. Ther., 48: 97-101, 2020.

Takizawa Y., Nishizawa S., Hayashi H., Kai J., Kobayashi A., Sugiyama T. Effect of intervention by hospital pharmacists on the number of drugs for at-home patients: A retrospective observational study. Jpn. Pharmacol. Ther., 48: 25-29, 2020.

Kawaguchi Y., Hanaoka J., Hayashi H., Fukuda Y., Iihara H., Suzuki A., Sugiyama T. Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis. Clin. Case Rep., 8: 347-350, 2020.

2019年

Masahiro YASUDA, Tomoya TACHI, Masahiro FUKUTA, Misa KATO, Kosuke SAITO, Aki YOSHIDA, Katsuhiro NAGAYA, Eriko SETTA, Michi UMEDA, Eiji MURAKAMI, Ken-ichiro AZUMA, Hitomi TERAMACHI, Chitoshi GOTO, Nutritional factors affecting length of hospital stay in patients undergoing cardiovascular surgery, Pharmazie, 74, 760-762, 2019.

Yoko INO, Akari SHIMAUCHI, Tomoya TACHI, Yoshihiro NOGUCHI, Chihiro SAKAI, Kazuhiro IGUCHI, Aki KANO, Hitomi TERAMACHI, Community pharmacy-level factors associated with medical and nursing home facility collaboration in Japan, Pharmazie, 74, 630-638, 2019.

Yoshihiro NOGUCHI, Hiroyuki NAGASAWA, Tomoya TACHI , Teruo TUCHIYA, Hitomi TERAMACHI, Signal detection of oral drug-induced dementia in chronic kidney disease patients using association rule mining and Bayesian confidence propagation neural network, Pharmazie, 74, 570-574, 2019.

Kazuhide TANAKA, Tomoya TACHI, Akiyo HORI, Tomohiro OSAWA, Katsuhiro NAGAYA, Teppei MAKINO, Seiji INOUE, Masahiro YASUDA, Takashi MIZUI, Takumi NAKADA, Chitoshi GOTO, Hitomi TERAMACHI, Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients, Pharmazie, 74, 439-442, 2019.

Takayuki SEKO, Tomoya TACHI, Hiroo HATAKEYAMA, Yoshihiro NOGUCHI, Hitomi TERAMACHI, Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy, Int. J. Clin. Pract., 73, e13349, 2019.

Chihiro SAKAI, Kazuhiro IGUCHI, Tomoya TACHI, Yoshihiro NOGUCHI, Shingo KATSUNO, Hitomi TERAMACHI, Association between Awareness of Taking Education on Medicines and Knowledge, Attitudes and Behavior about Medicines among Japanese High School Students, School Health, 15, 43-53, doi: 10.20812/jash.SH_098, 2019.

Hiroki ESAKI, Tomoya TACHI, Chitoshi GOTO, Yoshihiro NOGUCHI, Kazuhide TANAKA, Satoshi AOYAMA, Masahiro YASUDA, Takashi MIZUI, Masumi Yamamura, Hitomi Teramachi, Relationship between initial renal function and the inhibitory effect of dipeptidyl peptidase-4 inhibitor treatment on renal function decline, Pharmazie, 74, 374-382, 2019.

Chihiro SAKAI, Kazuhiro IGUCHI, Tomoya TACHI, Yoshihiro NOGUCHI, Shingo KATSUNO, Hitomi TERAMACHI, Factors Influencing Medicine Use Behavior in Adolescents in Japan Using a Bayesian Network Analysis, Front. Pharmacol., 10:494. doi: 10.3389/fphar.2019.00494, 2019.

Tomoya TACHI, Yuta KANEMATSU, Satoshi AOYAMA, Hayato KATSUNO, Manami OTSUBO, Anri UENO, Ikuto SUGITA, Aki YOSHIDA, Yoshihiro NOGUCHI, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi TERAMACHI, Analysis of Adverse Reactions Caused by Potentially Inappropriate Prescriptions and Related Medical Costs That are Avoidable using the Beers Criteria: the Japanese Version and Guidelines for Medical Treatment and its Safety in the Elderly 2015, Biol. Pharm. Bull., 42, 712-720, 2019.

Yoshihiro NOGUCHI, Yuumi TODA, Hiroki ESAKI, Takuya MATSUYAMA, Tomoya TACHI, Teruo TSUCHIYA, Hitomi TERAMACHI, Association between Dipeptidyl Peptidase-4 Inhibitors and Autoimmune Diseases: Data Mining of the Spontaneous Reporting System in Japan, Pharmazie, 74, 305-309, 2019.

Shuji YAMASHITA, Kazuhiro IGUCHI, Yoshihiro NOGUCHI, Chihiro SAKAI, Satoshi YOKOYAMA, Yoko INO, Hideki HAYASHI, Hitomi TERAMACHI, Magoichi SAKO, Tadashi SUGIYAMA, Color change in Perlodel® tablets induced by LED lighting - photolysis of bromocriptine mesylate, Pharmazie, 74, 286-289, 2019.

Katsuhito NAGAI, Sachiko OMOTANI, Akihiko ITO, Ikumi NISHIMURA, Yasutoshi HATSUDA, Junji MUKAI, Hitomi TERAMACHI, Michiaki MYOTOKU, Alterations in Pharmacokinetics of Orally Administered Carbamazepine in Rats Treated with Sodium alginate: Possible Interaction between Therapeutic Drugs and Semi-solid Enteral Nutrients, Drug Res., 69, 168-172, 2019.

上田祐稀乃, 甲斐絢子, 海野茜, 鈴木学, 小原道子, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正. かかりつけ薬剤師による処方監査の特徴. 日本地域薬局薬学会誌, 7: 76-85, 2019.

Suzuki M., Ueda Y., Uno A., Kai J., Kobayashi A., Obara M., Namaki M., Hayashi H., Tanase T., Hibino Y., Sugiyama T. Characteristics and economic effect of prescription audit related to unused drugs -Analysis of pharmaceutical intervention records-. Jpn. Pharmacol. Ther., 47:1985-1991, 2019.

Kobayashi A., Yamada M., Maegawa S., Hayashi H., Kai J., Sugiyama T. Questionnaire survey on the current status of pharmacist practice and patient needs related to home medical care. Jpn. Pharmacol. Ther., 47: 1807-1816, 2019.

小林篤史, 金地夏実, 甲斐絢子, 小原道子, 林秀樹, 棚瀬友啓, 日比野靖, 杉山正. 薬局薬剤師の無菌調製経験の実態とトレーナーを用いた無菌調製研修の効果. 薬理と治療, 47: 1817-1822, 2019.

林由依, 鈴木学, 味澤香苗, 甲斐絢子, 小林篤史, 小原道子, 生木庸寛, 國府田真綾, 金地夏実, 林秀樹, 棚瀬友啓, 土屋照雄, 杉山正. お薬手帳を活用した処方監査の特徴と経済効果―Pharmaceutical Intervention Record（薬学的介入報告）の分析―. 医療薬学, 45:425-432, 2019.

Hiroki NAKAYAMA, Naoki MASTUMARU, Katsura TSUKAMOTO，Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan，Pharm. Med., 33, 45-52, 2019.

Michio KIMURA, Shiori KAWACHI, Makiko GO, Mina IWAI, Eiseki USAMI, Hitomi TERAMACHI，Effect of the timing of discontinuation of last-line chemotherapy on patient prognosis in advanced and recurrent gastric cancer，Mol. Clin. Oncol., 10, 173-179, 2019.

舘知也，伊野陽子，島内あかり，野口義紘，堺千紘，井口和弘，加納亜紀，寺町ひとみ，薬局における医療施設・介護施設等との連携に関する調査，YAKUGAKU ZASSHI，139，327-339，2019．

Eiseki USAMI, Michio KIMURA, Shoya TAKENAKA, Mina IWAI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Tolerability and safety of real‑world use of pomalidomide in patients with relapsed/refractory multiple myeloma，Mol. Clin. Oncol., 10, 293-298, 2019.

Michio KIMURA, Eiseki USAMI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer，Anticancer Res., 39, 1029-1034, 2019.

Katsuhito NAGAI, Sachiko OMOTANI, Akihiko ITO, Ikumi NISHIMURA, Yasutoshi HATSUDA, Junji MUKAI, Hitomi TERAMACHI, Michiaki MYOTOKU，Alterations in Pharmacokinetics of Orally Administered Carbamazepine in Rats Treated with Sodium alginate: Possible Interaction between Therapeutic Drugs and Semi-solid Enteral Nutrients，Drug Res., 69, 168-172, 2019.

Takashi NIWA, Jun YONETAMARI, Nozomi HAYAMA, Ayasa FUJIBAYASHI, Syuri TAKEICHI, Keiko SUZUKI, Hirotoshi OHTA, Ayumi NIWA, Mayumi TSUCHIYA, Masayo YAMAMOTO, Daijiro HATAKEYAMA, Hideki HAYASHI, Michiko OBARA, Tadashi SUGIYAMA, Hisashi BABA, Akio SUZUKI, Nobuo MURAKAMI，Clinical impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry combined with antimicrobial stewardship interventions in patients with bloodstream infections in a Japanese tertiary hospital，Int J Clin Pract., DOI:10.1111/ijcp.13332, 2019.

Megumi NAKASHIMA, Hidenori TOYODA, Toshifumi TADA, Kazuyuki MIZUNO, Etsuko IIO, Yasuhito TANAKA, Tadashi SUGIYAMA, Tomoaki YOSHIMURA, Takashi KUMADA，Influence of Renal Dysfunction on Dose Reduction and Virological Efficacy of Regimens Combining Ribavirin and All-Oral Direct Acting Antivirals in Patients with Chronic Hepatitis C Virus Infection，Hepatol. Res., doi: 10.1111/hepr.13311, 2019.

鈴木大介，市江敏和, 高嶋祥匡, 林秀樹, 甲斐絢子, 畔柳敏弥, 杉山正，腹膜透析患者におけるプロトンポンプ阻害薬の使用と血清マグネシウム値：後ろ向きコホート研究，医療薬学, 45: 76-81, 2019.

Kengo OHASHI, Tomoko MATSUOKA, Yasutaka SHINODA, Takayuki MORI, Shinya　YOSHIDA, Tomoaki YOSHIMURA, Tadashi SUGIYAMA，Clinical outcome of pharmacist-led prospective audit with intervention and feedback after expansion from patients using specific antibiotics to include those using whole injectable antibiotics，Eur J Clin Microbiol Infect Dis., 38: 593-600, 2019.

　2018年

Hiroki NAKAYAMA, Naoki MASTUMARU, Katsura TSUKAMOTO，Delays in New Drug Applications and Associated Factors for Orphan Anticancer Drugs in Japan Compared with the USA. 32(6), 403-412, 2018.

Katsura TSUKAMOTO, Miriam CNOP, Daichi MORI, Shoen KUME, Takayuki ANAZAWA T, Masako DOI, Kazuhiko CHIKAZAWA, Naoki MATSUMARU，Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework，Ther. Innov. Reg. Sci., https://doi.org/10.1177/2168479018795854, 2018.

Kaori KIDO, Naoki MATSUMARU, Katsura TSUKAMOTO，Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective，Ther. Innov. Reg. Sci., https://doi.org/10.1177/2168479018791136, 2018.

Hiroki NAKAYAMA, Naoki MATSUMARU, Katsura TSUKAMOTO，The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States，Invest. New Drugs, https://doi.org/10.1007/s10637-018-0612-y, 2018.

Hiroki NAKAYAMA, Naoki MATSUMARU, Katsura TSUKAMOTO，Unique characteristics of regulatory approval and pivotal studies of orphan anticancer drugs in Japan，Invest. New Drugs, 36(4), 702-708, 2018.

Makoto TANAKA, Naoki MATSUMARU, Katsura TSUKAMOTO，Influence of Breakthrough Therapy Designation in the United States on Oncology Drug Development Timelines in Japan，Pharm. Med., 32(3), 201-207, 2018.

Makoto TANAKA, Naoki MATSUMARU, Katsura TSUKAMOTO，Influence of Expedited Programs in the United States on Oncology Drug Development in Japan
Ther. Innov. Reg. Sci., https://doi.org/10.1177/2168479018769288, 2018.

Sachiko OMOTANI, Katsuji TANI, Mai AOE, Seiji ESAKI, Katsuhito NAGAI, Yasutoshi HATSUDA, Junji MUKAI, Hitomi TERAMACHI, Michiaki MYOTOKU，Bactericidal effects of deep ultraviolet light-emitting diode for solutions during intravenous infusion，Int. J. Med. Sci., 15, 101-107, 2018.

吉田阿希，舘知也，兼松勇汰，杉田郁人，野口義紘，大澤友裕，安田昌宏，水井貴詞，後藤千寿，寺町ひとみ，がん患者における健康食品およびサプリメントの使用に影響を及ぼす要因の解明，医療薬学，44，49-53，2018．

Michio KIMURA, Mina IWAI, Eiseki USAMI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Prognostic factors in patients with advanced and recurrent colorectal cancer receiving last-line chemotherapy，Pharmazie, 73, 115-119, 2018.

Yoshihiro NOGUCHI, Anri UENO, Manami OTSUBO, Hayato KATSUNO, Ikuto SUGITA, Yuta KANEMATSU, Aki YOSHIDA, Hiroki ESAKI, Tomoya TACHI, Hitomi TERAMACHI，A New Search Method Using Association Rule Mining for Drug-Drug Interaction Based on Spontaneous Report System，Front. Pharmacol., 9:197. doi: 10.3389/fphar.2018.00197, 2018.

Tomoya TACHI, Kosuke SAITO, Hiroki ESAKI, Ikuto SUGITA, Aki YOSHIDA, Yuta KANEMATSU, Yoshihiro NOGUCHI, Michi UMEDA, Masahiro YASUDA, Takashi MIZUI, Teruo TSUCHIYA, Chitoshi GOTO, Hitomi TERAMACHI，The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies，J. Pharm. Health Care Sci., 4:6. doi.org/10.1186/s40780-018-0102-6, 2018.

Eiseki USAMI, Michio KIMURA, Katsuya FURUKAWA, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Controllable vitamin K deficiency under high-dose oral menatetrenone administration - a case report，Pharmazie, 73, 234-236, 2018.

伊野陽子，松山卓矢，舘知也，野口義紘，寺町ひとみ，薬学生に対する多職種連携医療実習の効果―RIPLS（Readiness for Interprofessional Learning Scale）、IEPS（Interdisciplinary Education Perception Scale）を中心とした短期的効果―，医療薬学，44，191-202，2018．

Yoshihiro NOGUCHI, Anri UENO, Manami OTSUBO, Hayato KATSUNO, Ikuto SUGITA, Yuta KANEMATSU, Aki YOSHIDA, Hiroki ESAKI, Tomoya TACHI, Hitomi TERAMACHI，A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system, BMC Bioinformatics，19:124. doi: org/10.1186/s12859-018-2137-y, 2018.

Kazuhide TANAKA, Akiyo HORI, Tomoya TACHI, Tomohiro OSAWA, Katsuhiro NAGAYA, Teppei MAKINO, Seiji INOUE, Masahiro YASUDA, Takashi MIZUI, Takumi NAKADA, Chitoshi GOTO HITOMI Teramachi，Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast cancer，J. Pharm. Health Care Sci., 4:9. doi.org/10.1186/s40780-018-0105-3, 2018.

Mina IWAI, Daisuke ITO, Hiroki ASANO, Shino ADACHI, Kazutomo OKADA, Michio KIMURA, Eiseki USAMI, Koichi MATSUO, Tomoaki YOSHIMURA, Hitomi TERAMACHI，Evaluation of the safety of ramucirumab in Japanese patients with advanced gastric cancer，Pharmazie, 73, 309-312, 2018.

Yoshihiro NOGUCHI, Anri UENO, Hayato KATSUNO, Manami OTSUBO, Aki YOSHIDA, Yuta KANEMATSU, Ikuto SUGITA, Tomoya TACHI, Teruo TSUCHIYA, Hitomi TERAMACHI，Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database，J. Pharm. Health Care Sci., 4:10. doi.org/10.1186/s40780-018-0106-2, 2018.

舘知也，野口義紘，水井貴詞，山下修司，堺千紘，横山聡，伊野陽子，井口和弘，福田聖啓，安田昌宏，後藤千寿，寺町ひとみ，改訂薬学教育モデル・コアカリキュラムにおける実務実習に向けた大学・施設間の情報共有の実施と薬剤師の意識調査，医療薬学，44，251-259，2018．

Hiroyuki NAGASAWA, Tomoya TACHI, Ikuto SUGITA, Hiroki ESAKI, Aki YOSHIDA, Yuta KANEMATSU, Yoshihiro NOGUCHI, Yukio KOBAYASHI, Etsuko ICHIKAWA, Teruo TSUCHIYA, Hitomi TERAMACHI，The Effect of Quality of Life on Medication Compliance Among Dialysis Patients，Front. Pharmacol., 9:488.doi: 10.3389/fphar.2018.00488, 2018.

田口真穂，重山昌人，田村大喜，森和也，村田実希郎，埴岡伸光，山本浩充，寺町ひとみ，処方改良Mohsペーストの保存安定性評価，日本緩和医療薬学雑誌，11，19-25，2018．

Yoshihiro NOGUCHI, Hayato KATSUNO, Anri UENO, Manami OTSUBO, Aki YOSHIDA, Yuta KANEMATSU,　Ikuto SUGITA, Hiroki ESAKI, Tomoya TACHI, Teruo TSUCHIYA, Hitomi TERAMACHI，Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report database，J. Pharm. Health Care Sci., 4:15. doi.org/10.1186/s40780-018-0109-z, 2018.

Tomoya TACHI, Kosuke SAITO, Hiroki ESAKI, Yuta KANEMATSU, Aki YOSHIDA, Ikuto SUGITA, Yoshihiro NOGUCHI, Teppei MAKINO, Michi UMEDA, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi TERAMACHI，Medical and economic factors influencing generic drug use in the Japanese public health system: Influencing factors in different populations，Int. J. Health Plann. Manage., 33, 489-201, 2018.

Hiroyuki NAGASAWA, Ikuto SUGITA, Tomoya TACHI, Hiroki ESAKI, Aki YOSHIDA, Yuta KANEMATSU, Yoshihiro NOGUCHI, Yukio KOBAYASHI, Etsuko ICHIKAWA, Teruo TSUCHIYA, Hitomi TERAMACHI，The Relationship Between Dialysis Patients' Quality of Life and Caregivers' Quality of Life
Front. Pharmacol., 9:770.doi: 10.3389/fphar.2018.00770, 2018.

Yoko INO, Tomoya TACHI, Anri UENO, Manami OTSUBO, Hayato KATSUNO, Yoshihiro NOGUCHI, Chihiro SAKAI, Kazuhiro IGUCHI, Chihiro KAWAKAMI, Kazuhiko FUJISAKI, Hitomi TERAMACHI，Clinic-level factors associated with collaboration with community pharmacies in Japan，Pharmazie, 73, 545-552, 2018.

Michio KIMURA, Eiseki USAMI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer，J. Oncol. Pharm. Pract., 24, 403-411, 2018.

Tomoya TACHI, Aki YOSHIDA, Yuta KANEMATSU, Ikuto SUGITA, Yoshihiro NOGUCHI, Tomohiro OSAWA, Masahiro YASUDA, Takashi MIZUI, Chitoshi GOTO, Hitomi Teramachi，Factors influencing the use of over-the-counter drugs and health foods/supplements，Pharmazie, 73, 598-604, 2018.

Sachiko OMOTANI, Mai AOE, Seiji ESAKI, Katsuhito NAGAI, Yasutoshi HATSUDA, Junji MUKAI, Hitomi TERAMACHI, Michiaki MYOTOKU，Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion，Ann. Nutr. Metab., 73, 227-233, 2018.

Maho TAGUCHI, Masato SHIGEYAMA, Noriko OGAWA, Mikio MURATA, Nobumitsu HANIOKA, Hiromitsu YAMAMOTO, Hitomi TERAMACHI，Evaluation of Tumor Tissue Fixation Effects of Formulation Modified Mohs Pastes in Mice and Their Water-Absorbing Properties，Biol. Pharm. Bull., 41, 1824-1829, 2018.

Yasutaka SHINODA, Keiji NAKASHIMA, Kengo OHASHI, Tomoko MATSUOKA, Kiyohito KAWASHIMA, Hiroshi SOBAJIMA, Tadashi SUGIYAMA, Tomoaki YOSHIMURA，Early cure of Mycobacterium abscessus tunnel infection while maintaining peritoneal dialysis through a combination of antibiotic treatment and catheter replacement，Open J. Clin. Med. Case Rep., 1473, 2018

Yuto YAMADA, Yuta OHNO, Takashi NIWA, Hiroko KATO-HAYASHI, Hideki HAYASHI, Takashi IBUKA, Hiroshi ARAKI, Tadashi SUGIYAMA, Masahito SHIMIZU, Akio SUZUKI，Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis
J. Clin. Pharm. Ther., doi: 10.1111/jcpt.12800. 2018

味澤香苗，鈴木学，林由依，甲斐絢子，小林篤史，小原道子，生木庸寛，國府田真綾，金地夏実，林秀樹，棚瀬友啓，土屋照雄，杉山正，重複投薬・相互作用等防止加算関連業務の分析と経済効果―Pharmaceutical Intervention Record（薬学的介入報告）の分析―，医療薬学, 44: 599-606, 2018

Kodai SUZUKI, Hideshi OKADA, Shozo YOSHIDA, Haruka OKAMOTO, Akio SUZUKI, Keiko SUZUKI, Yuto YAMADA, Hideki HAYASHI, Ryu YASUDA, Tetsuya FUKUTA, Yuichiro KITAGAWA, Takahito MIYAKE, Tomonori KAWAGUCHI, Takatomo WATANABE, Tomoaki DOI, Keisuke KUMADA, Hiroaki USHIKOSHI, Tadashi SUGIYAMA, Yoshinori ITOH, Shinji OGURA，Effect of High-Flow High-Volume-Intermittent Hemodiafiltration on Metformin-Associated Lactic Acidosis with Circulatory Failure: A Case Report，J. Med. Case Rep., 2018 Sep 29;12(1):280. doi: 10.1186/s13256-018-1809-6.

Shuuji YAMASHITA, Kazuhiro IGUCHI, Yoshihiro NOGUCHI, Chihiro SAKAI, Satoshi YOKOYAMA, Yoko INO, Hideki HAYASHI, Hitomi TERAMACHI, Magoichi SAKO, Tadashi SUGIYAMA，Color Change in Perlodel® Tablet Induced by LED Lighting - Photolysis of bromocriptine mesylate-，Pharmazie, 73: , 2018.

國府田真綾，鈴木学，金地夏実，福本実咲，桑原千明，林秀樹，亀山千里，生木庸寛，小原道子，棚瀬友啓，杉山正，かかりつけ薬剤師を指名している患者の行動分析および意識調査，医療薬学, 44: 395-402, 2018.

Shuuji YAMASHITA, Kazuhiro IGUCHI, Yoshihiro NOGUCHI, Chihiro SAKAI, Satoshi YOKOYAMA, Yoko INO, Hideki HAYASHI, Hitomi TERAMACHI, Magoichi SAKO, Tadashi SUGIYAMA，Changes in the quality of medicines during storage under LED lighting and consideration of countermeasures，J. Pharm. Health Care Sci., doi.org/10.1186/s40780-018-0108-0 , 2018.

中島誠, 石崎直樹, 大迫政彦，林秀樹, 杉山正，腹部手術施行患者におけるエノキサパリンナトリウム短期使用の有効性および安全性評価，医療薬学, 44: 341-348 , 2018

大橋健吾，篠田康孝，松岡知子，吉田真也，森卓之，林秀樹，吉村知哲，杉山正，全注射用抗菌薬使用患者を対象とした薬剤師によるprospective audit and feedback の介入状況評価，医療薬学, 44: 305-312, 2018.

金地夏実，鈴木学，國府田真綾，桑原千明，福本実咲，林秀樹，亀山千里，生木庸寛，小原道子，棚瀬友啓，杉山正，かかりつけ薬剤師が在籍する薬局の業務分析，医療薬学, 44: 313-320, 2018.

鈴木学，國府田真綾，金地夏実，福本実咲，桑原千明，林秀樹，棚瀬友啓，小原道子，山崎太，杉山正，重複投薬・相互作用等防止加算関連業務が調剤報酬に及ぼす影響―Pharmaceutical Intervention Record（薬学的介入報告）の分析―，日本薬剤師会雑誌, 70: 673-678, 2018.

Tatsuya HIROSE, Shinoda YASUTAKA, Ayaka KURODA, Aya YOSHIDA, Machiko MITSUOKA, Kouki MORI, Yuki KAWACHI, Akihiro MORIYA, Kouji TANAKA, Atsuko TAKEDA, Tomoaki YOSHIMURA, Tadashi SUGIYAMA，Efficacy and safety of Daikenchuto for constipation and dose-dependent differences in clinical effects，Int. J. Chronic Dis., doi.10.1155/2018/1296717, 2018.

鈴木学，桑原千明，福本実咲，金地夏実，國府田真綾，浅川博翔，林秀樹，亀山千里，棚瀬友啓，山崎太，杉山正，2016年度調剤報酬改定1年後における保険薬局の対応状況，日本薬剤師会雑誌, 70: 285-289, 2018.

Kengo OHASHI, Tomoko MATSUOKA, Yasutaka SHINODA, Yasuyuki FUKAMI, Joe SHINDOH, Tetsuya YAGI, Tomoaki YOSHIMURA, Tadashi SUGIYAMA，Evaluation of Treatment Outcomes of Patients with MRSA Bacteremia following Antimicrobial Stewardship Programs with Pharmacist Intervention，Int. J. Clin. Pract. 2018 Feb 8. doi: 10.1111/ijcp.13065, 2018.

Minako NAWA-NIshigaki, Ryo KOBAYASHI, Akio SUZUKI, Chiemi HIROSE, Rie MATSUOKA, Ryutaro MORI, Manabu FUTAMURA, Tadashi SUGIYAMA, Kazuhiro YOSHIDA, Yoshinori ITOH，Control of nausea and vomiting in patients receiving　anthracycline/cyclophosphamide chemotherapy for breast cancer，
Anticancer Res., 38: 877-884, 2018.

市江敏和, 浅川博翔, 鈴木大介, 寺崎嘉正, 林秀樹, 畔柳敏弥, 杉山正，医薬品リスク管理計画における患者向けリスク最小化活動の規定状況に関する調査研究，日本病院薬剤師会雑誌，54: 409-415, 2018.

長谷川栞，加藤大和，松井利亘，畠平春奈，笹岡沙也加，元岡佑美，中尾智史，向井梨々香，島田和代，上田夏実，中村光浩，中医協公開資料(医薬品の薬価収載について)を用いた新医薬品薬価算定状況の調査，医薬品情報学，20，120-128，2018.

矢島聖子，島内あかり，堺千紘，横山聡，伊野陽子，松永俊之，寺町ひとみ，中村光浩，井口和弘，政府統計データを用いた薬局に従事する薬剤師の分布に関する調査，薬学雑誌，138，991-1000，2018．

堺千紘，横山聡，伊野陽子，山下修司，野口義紘，井口和弘，寺町ひとみ，薬局におけるプレアボイド事例の分析，薬局薬学，10，201-207，2018．

Satoshi YOKOYAMA, Satoko YAJIMA, Akari SHIMAUCHI, Chihiro SAKAI, Shuji YAMASHITA, Yoshihiro NOGUCHI, Yoko INO, Kazuhiro IGUCHI, Hitomi TERAMACHI，Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting，Can. Pharm. J. (Ott), 151, 377-382, 2018.

　2017年

Michio KIMURA, Eiseki USAMI, Mina IWAI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer under oral trifluridine-tipiracil (TAS-102) chemotherapy，Pharmazie, 72, 49-52, 2017.

野口義紘，林勇汰，吉田阿希，杉田郁人，江﨑宏樹，齊藤康介，臼井一将，加藤未紗，舘知也，寺町ひとみ，高齢者において有害事象の予後が悪化する可能性がある内用医薬品の探索，医薬品情報学，18，277-283，2017．

田口真穂，重山昌人，伊東奈保美，小川法子，高橋知里，村田実希郎，埴岡伸光，山本浩充，寺町ひとみ，デンプン非含有Mohsペーストの調製と製剤評価，YAKUGAKU ZASSHI，137，477-484，2017．

Mina IWAI, Michio KIMURA, Eiseki USAMI, Tomoaki YOSHIMURA, Hitomi TERAMACHI，Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer，Mol. Clin. Oncol., 6, 794-798, 2017.

Eiseki USAMI, Michio KIMURA, Mina IWAI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase，Mol. Clin. Oncol., 6, 955-959, 2017.

Tomoko MATSUOKA, Misa KATO, Yasutaka SHINODA, Kengo OHASHI, Shinya YOSHIDA, Takayuki MORI, Tomoya TACHI, Tomoaki YOSHIMURA, Hitomi TERAMACHI，Evaluation of antimicrobial stewardship (AS) for appropriate use of antimicrobial agents，Pharmazie, 72, 296-299, 2017.

Kazumasa USUI, Hiromi MORI, Tomoya TACHI, Tomohiro MATSUMURA, Koki MORI, Ako TAKEDA, Yoshihiro NOGUCHI, Tomoaki YOSHIMURA, Hitomi TERAMACHI，A rapid method to screen poisoning causative agents in an acute care hospital in Japan，J. Clin. Pharm. Ther., 42, 454-460, 2017.

Takayuki SEKO, Tomoya TACHI, Naoki KAWASHIMA, Teruo MAEDA, Minako YASUDA, Yoshihiro NOGUCHI, Hitomi TERAMACHI，Economic evaluation of infection control activities，J. Hosp. Infect., 96, 371-376. 2017.

Michio KIMURA, Makiko GO, Mina IWAI, Eiseki USAMI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancer，Mol. Clin. Oncol., 7, 486-492, 2017.

Michio KIMURA, Makiko GO, Mina IWAI, Eiseki USAMI, Hitomi TERAMACHI, Tomoaki YOSHIMURA，Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents，J. Oncol. Pharm. Pract., 23, 413-421, 2017.

松岡知子，篠田康孝，大橋健吾，吉田真也，加藤未紗，森卓之，吉村知哲，寺町ひとみ，中等度肝機能障害患者におけるカスポファンギンの安全性に関する検討，日本化学療法学会，65，597-601，2017．

伊野陽子，上野杏莉，舘知也，大坪愛実，勝野隼人，杉田郁人，兼松勇汰，吉田阿希，野口義紘，堺千紘，井口和弘，川上ちひろ，藤崎和彦，寺町ひとみ，病院および診療所における薬局との連携に関する調査，医療薬学，43，533-551，2017．

Tomoko MATSUOKA, Shinya YOSHIDA, Kengo OHASHI, Yasutaka SHINODA, Misa KATO, Takayuki MORI, Tomoaki YOSHIMURA, Koji TANAKA, Ayako SATO, Takashi GOTO, Yuko ASANO, Shiomi ISHIGO, Joe SHINDO, Yoshinori FUJIMOTO, Hitomi TERAMACHI，Evaluation of efficacy and clinical utility of potassium peroxymonosulfate-based disinfectants，Can. J. Infect. Control, 32, 93-97, 2017.

Hiroki ESAKI, Tomoya TACHI, Chitoshi GOTO, Ikuto SUGITA, Yuta KANEMATSU, Aki YOSHIDA, Kosuke SAITO, Yoshihiro NOGUCHI, Yuki OHNO, Satoshi AOYAMA, Masahiro YASUDA, Takashi MIZUI, Masumi YAMAMURA, Hitomi TERAMACHI，Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus，Front. Pharmacol., 8:835. doi: 10.3389/fphar.2017.00835, 2017.

野口義紘，杉田郁人，林勇汰，吉田阿希，上野杏莉，大坪愛実，勝野隼人，江﨑宏樹，齊藤康介，舘知也，寺町ひとみ，安全性シグナル指標を用いた経口非ステロイド抗炎症薬の既知の有害事象である消化器障害のリスク評価とその注意点，医薬品情報学，19，127-132，2017．

鈴木大介, 市江敏和, 林秀樹, 畔柳敏弥, 杉山正，HMG-CoA還元酵素阻害薬と炭酸ランタンの併用による脂質プロファイルと血清リン値の変動に関する検討，日本腎臓病薬物療法学会誌. 6: 181-187, 2017.

中島誠, 高橋武士, 中木原由佳, 福元裕介, 平松さやか, 林秀樹, 杉山正，腎機能低下患者へのtazobactam/piperacillinの投与が使用量サーベイランスに与える影響，医療薬学, 43: 648-653, 2017.

Yo KAWAGUCHI, Jun HANAOKA, Hideki HAYASHI, Naoki MIZUSAKI, Hirotoshi IIHARA, Yoshinori ITOH, Tadashi SUGIYAMA，Clinical Efficacy of Afatinib Treatment for a Patient with Leptomeningeal Carcinomatosis，Chemotherapy 62:147-150, 2017.

Hisao IMAI, Kyoichi KAIRA, Ichiro NARUSE, Hideki HAYASHI, Hirotoshi IIHARA, Yutaro KITA, Naoki MIZUSAKI, Takayuki ASAO, Yoshinori ITOH, Tadashi SUGIYAMA, Koichi MINATO, Masanobu YAMADA，Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis
Cancer Chemother. Pharmacol. 79: 209-213, 2017.

Daisuke SUZUKI, Toshikazu ICHIE, Hideki HAYASHI, Yoji SUGIURA, Tadashi SUGIYAMA，Efficacy of sucroferric oxyhydroxide treatment in Japanese hemodialysis patients and its effect on gastrointestinal symptoms，Pharmazie, 72: 118-122 , 2017.

鈴木学，川瀬晶子，棚瀬友啓，山内茂義，伊藤正隆，林秀樹，山崎太，杉山正，Pharmaceutical Intervention Record（薬学的介入報告）事業の実施と成果，日本薬剤師会雑誌, 69: 141-146, 2017.

長谷川栞，畠平春奈，長沼美沙，島内あかり，笹岡沙也加，元岡佑美，福田昌穂，阿部純子，中尾智史，加藤大和，大森智史，井口和弘，中村光浩，有害事象自発報告データベースを用いたOTC医薬品の解熱鎮痛消炎剤の有害事象発現傾向の調査，薬学雑誌，137，1301-1311，2017.

百瀬和浩，竹中登一，中村光浩，原英彰，日本におけるアカデミア発の創薬支援に関する経緯 - 1990～2017にかけての創薬支援 -，薬史学雑誌，52，1-63，2017.

Satoshi YOKOYAMA, Satoko YAJIMA, Chihiro SAKAI, Shuji YAMASHITA, Yoshihiro NOGUCHI, Yoko INO, Kazuhiro IGUCHI, Hitomi TERAMACHI，Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer，Can. Pharm. J. (Ott), 150, 362-365, 2017.

島内あかり，長沼美紗，笹岡沙也加，畠平春奈，元岡佑美，長谷川栞，福田昌穂，中尾智史，堺千紘，横山聡，伊野陽子，中村光浩，井口和弘，OTC医薬品における添付文書記載状況調査，薬学雑誌，138，259-267，2017．